+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Europe Organoids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type; Application; Source

  • PDF Icon

    Report

  • 99 Pages
  • February 2021
  • Region: Europe
  • The Insight Partners
  • ID: 5295140
UP TO OFF until Jun 30th 2023
Internal Organoids segment is expected to drive the growth of the Europe Organoids market by Technology

According to the latest study on ‘Europe Organoids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type, Application, Source, and Country,’ the Europe Organoids market was valued at US$ 247.85 million in 2019 and is projected to reach US$ 1,260.08 million by 2027; it is expected to grow at a CAGR of 22.5% during 2020-2027. The report highlights the trends prevailing in the Europe organoids market and the factors driving the market along with those that act as deterrents to its growth.

Based on type, the organoids market is segmented stomach, intestine, liver, pancreas, lung, brain, kidney, and others. In 2019, the stomach segment accounted for the largest share of the Europe organoids market. The growth of the segment attributes to growth of internal Organoids segment is attributed to the rising stomach disorders are some of the primary factors contributing to the dominance of the segment in the Europe organoids market. Additionally, the outbreak of the COVID-19 pandemic has highly affected the countries in the European region.

STEMCELL Technologies, Inc., Cellesce Ltd., Hubrecht Organoid Technology, Definigen, 3Dnamics, Inc.

Organoid Therapeutics, PeproTech, Inc., Thermo Fisher Scientific, Corning Incorporated (Life Sciences)

Merck KGgA. are among the prominent players present in the organoids market. The market players are focused on mergers and acquisitions to sustain their position in the market. For instance, in September 2018 STEMCELL Technologies Signs partnership agreement with Brigham and Women’s Hospital to Commercialize Human Pluripotent Stem Cell-Derived Kidney Organoid Culture System.

The report segments the Europe Organoids market as follows:

By Type
  • Stomach
  • Intestine
  • Liver
  • Pancreas
  • Lung
  • Brain
  • Kidney
  • Others

By Application
  • Developmental Biology
  • Disease Pathology of Infectious Disease
  • Regenerative Medicine
  • Drug Toxicity and Efficacy Testing
  • Drug Discovery and Personalized Medicine
  • Others

By Source
  • Pluripotent Stem Cells
  • Organ-specific Adult Stem Cells

By Country
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe


Reasons to Buy
  • To understand the Europe organoids market landscape and identify market segments that are most likely to guarantee a strong return.
  • To stay ahead in comprehending the ever-changing competitive landscape of the Europe organoids market.
  • To Efficiently plan M&A and partnership deals in the Europe organoids market by identifying market segments with the most promising probable sales.
  • To help take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments in the Europe organoids market.
  • To.
  • Obtain market revenue forecast from 2019 to 2027 in various segments of the Europe organoids market.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Organoids Market- By Type
1.3.2 Europe Organoids Market- By Application
1.3.3 Europe Organoids Market- By Source
1.3.4 Europe Organoids Market- By Country
2. Organoids Market- Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Organoids Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion
5. Organoids Market- Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Demand for Tumor Modelling and Biobanking
5.1.2 Increasing Adoption of Personalized Drugs
5.1.3 Growing Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Issues Related to the Incorporation of Organoids into Existing Workflows
5.2.2 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Increasing Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Combining Organoid with Organ-On-A-Chip
5.5 Impact Analysis
6. Organoids Market Analysis - By Type
6.1 Overview
6.2 Organoids Market Revenue Share, by Type (2019 and 2027)
6.3 Stomach
6.3.1 Overview
6.3.2 Stomach: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
6.4 Intestine
6.4.1 Overview
6.4.2 Intestine: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
6.5 Liver
6.5.1 Overview
6.5.2 Liver: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
6.6 Pancreas
6.6.1 Overview
6.6.2 Pancreas: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
6.7 Lung
6.7.1 Overview
6.7.2 Lung: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
6.8 Brain
6.8.1 Overview
6.8.2 Brain: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
6.9 Kidney
6.9.1 Overview
6.9.2 Kidney: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
6.10 Others
6.10.1 Overview
6.10.2 Others: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
7. Europe Organoids Market Analysis - By Application
7.1 Overview
7.2 Organoids Market Share, by Application, 2019 and 2027, (%)
7.3 Developmental Biology
7.3.1 Overview
7.3.2 Developmental Biology: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Disease Pathology of Infectious Disease
7.4.1 Overview
7.4.2 Disease Pathology of Infectious Disease: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Regenerative Medicine
7.5.1 Overview
7.5.2 Regenerative Medicine: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Drug Toxicity and Efficacy Testing
7.6.1 Overview
7.6.2 Drug Toxicity and Efficacy Testing: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
7.7 Drug Discovery and Personalized Medicine
7.7.1 Overview
7.7.2 Drug Discovery and Personalized Medicine: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
8. Europe Organoids Market Analysis - By Source
8.1 Overview
8.2 Organoids Market Share, by Source, 2019 and 2027, (%)
8.3 Pluripotent Stem Cells
8.3.1 Overview
8.3.2 Pluripotent Stem Cells: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Organ-Specific Adult Stem Cells
8.4.1 Overview
8.4.2 Organ-Specific Adult Stem Cells: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
9. Europe Organoids Market - Country Analysis
9.1 Overview
9.1.1 Europe Organoids Market - Revenue and Forecast to 2027 (USD Million)
9.1.2 Europe Organoids Market, by Type, 2018-2027 (USD Million)
9.1.3 Europe Organoids Market, by Application, 2018-2027 (USD Million)
9.1.4 Europe Organoids Market, by Source, 2018-2027 (USD Million)
9.1.5 Europe Organoids Market, by Country, 2019 & 2027 (%)
9.1.6 Germany: Organoids Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 Germany: Organoids Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 Germany: Organoids Market, by Type, 2018-2027 (USD Million)
9.1.6.3 Germany: Organoids Market, by Application, 2018-2027 (USD Million)
9.1.6.4 Germany: Organoids Market, by Source, 2018-2027 (USD million)
9.1.7 UK: Organoids Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 UK Organoids Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 UK: Organoids Market, by Type, 2018-2027 (USD Million)
9.1.7.3 UK: Organoids Market, by Application, 2018-2027 (USD Million)
9.1.7.4 UK: Organoids Market, by Source, 2018-2027 (USD million)
9.1.8 France: Organoids Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 France: Organoids Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 France: Organoids Market, by Type, 2018-2027 (USD Million)
9.1.8.3 France: Organoids Market, by Application, 2018-2027 (USD Million)
9.1.8.4 France: Organoids Market, by Source, 2018-2027 (USD million)
9.1.9 Spain: Organoids Market - Revenue and Forecast to 2027 (USD Million)
9.1.9.1 Spain: Organoids Market - Revenue and Forecast to 2027 (USD Million)
9.1.9.2 Spain: Organoids Market, by Type, 2018-2027 (USD Million)
9.1.9.3 Spain: Organoids Market, by Application, 2018-2027 (USD Million)
9.1.9.4 Spain: Organoids Market, by Source, 2018-2027 (USD million)
9.1.10 Italy: Organoids Market - Revenue and Forecast to 2027 (USD Million)
9.1.10.1 Italy: Organoids Market - Revenue and Forecast to 2027 (USD Million)
9.1.10.2 Italy: Organoids Market, by Type, 2018-2027 (USD Million)
9.1.10.3 Italy: Organoids Market, by Application, 2018-2027 (USD Million)
9.1.10.4 Italy: Organoids Market, by Source, 2018-2027 (USD million)
9.1.11 Rest of Europe: Organoids Market - Revenue and Forecast to 2027 (USD Million)
9.1.11.1 Rest of Europe: Organoids Market - Revenue and Forecast to 2027 (USD Million)
9.1.11.2 Rest of Europe: Organoids Market, by Type, 2018-2027 (USD Million)
9.1.11.3 Rest of Europe: Organoids Market, by Application, 2018-2027 (USD Million)
9.1.11.4 Rest of Europe: Organoids Market, by Source, 2018-2027 (USD million)
10. Impact Of COVID-19 Pandemic on Europe Organoids Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 STEMCELL Technologies Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Cellesce Ltd
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Hubrecht Organoid Technology
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Definigen
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 PeproTech, Inc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 THERMO FISHER SCIENTIFIC INC.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Corning Incorporated
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 MERCK KGaA
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About the Publisher
12.2 Glossary of Terms
List of Tables
Table 1. Europe Organoids Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 2. Europe Organoids Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 3. Europe Organoids Market, by Source - Revenue and Forecast to 2027 (USD Million)
Table 4. Germany Organoids Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 5. Germany Organoids Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 6. Germany Organoids Market, by Source - Revenue and Forecast to 2027 (USD Million)
Table 7. UK Organoids Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 8. UK Organoids Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 9. UK Organoids Market, by Source - Revenue and Forecast to 2027 (USD Million)
Table 10. France Organoids Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 11. France Organoids Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 12. France Organoids Market, by Source - Revenue and Forecast to 2027 (USD Million)
Table 13. Spain Organoids Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 14. Spain Organoids Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 15. Spain Organoids Market, by Source - Revenue and Forecast to 2027 (USD Million)
Table 16. Italy Organoids Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 17. Italy Organoids Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 18. Italy Organoids Market, by Source - Revenue and Forecast to 2027 (USD Million)
Table 19. Rest of Europe Organoids Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 20. Rest of Europe Organoids Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 21. Rest of Europe Organoids Market, by Source - Revenue and Forecast to 2027 (USD Million)
Table 22. Glossary of Terms, Organoids Market
List of Figures
Figure 1. Organoids Market Segmentation
Figure 2. Organoids Segmentation, By Country
Figure 3. Europe Organoids Market Overview
Figure 4. Liver Organoids Segment Held Largest Share of Organoids Market
Figure 5. UK to Show Remarkable Growth During Forecast Period
Figure 6. Europe Organoids Market- Leading Country Markets (US$ Million)
Figure 8. PEST Analysis
Figure 9. Organoids Market Impact Analysis of Driver and Restraints
Figure 10. Organoids Market Revenue Share, by Type (2019 and 2027)
Figure 11. Stomach: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Intestine: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Liver: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Pancreas Organoids Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Lung: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. Brain: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Kidney: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
Figure 18. Others: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Organoids Market Share, by Application, 2019 and 2027 (%)
Figure 20. Developmental Biology: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Disease Pathology of Infectious Disease: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Regenerative Medicine: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Drug Toxicity and Efficacy Testing: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Drug Discovery and Personalized Medicine: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Others: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Organoids Market Share, by Source, 2019 and 2027 (%)
Figure 27. Pluripotent Stem Cells: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
Figure 28. Organ-Specific Adult Stem Cells: Organoids Market - Revenue and Forecast to 2027 (US$ Million)
Figure 29. Europe: Organoids Market, by Key Country - Revenue (2019) (USD Million)
Figure 30. Europe Organoids Market Revenue and Forecast to 2027 (USD Million)
Figure 31. Europe: Organoids Market, by Country, 2019 & 2027 (%)
Figure 32. Germany: Organoids Market - Revenue and Forecast to 2027 (USD Million)
Figure 33. UK: Organoids Market - Revenue and Forecast to 2027 (USD Million)
Figure 34. France: Organoids Market - Revenue and Forecast to 2027 (USD Million)
Figure 35. Spain: Organoids Market - Revenue and Forecast to 2027 (USD Million)
Figure 36. Italy: Organoids Market - Revenue and Forecast to 2027 (USD Million)
Figure 37. Rest of Europe: Organoids Market - Revenue and Forecast to 2027 (USD Million)
Figure 38. Impact of COVID-19 Pandemic In European Country Markets

Companies Mentioned

A selection of companies mentioned in this report includes:

  • STEMCELL Technologies, Inc.
  • Cellesce Ltd.
  • Hubrecht Organoid Technology
  • Definigen
  • 3Dnamics, Inc.
  • Organoid Therapeutics
  • PeproTech, Inc.
  • Thermo Fisher Scientific
  • Corning Incorporated (Life Sciences)
  • Merck KGgA